Antikoagulation bei Vorhofflimmern. ACTIVE-Studie (Aterial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events)
Standard
Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Antikoagulation bei Vorhofflimmern. ACTIVE-Studie (Aterial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events)
AU - Meinertz, T
PY - 2007/8
Y1 - 2007/8
KW - Administration, Oral
KW - Angiotensin II Type 1 Receptor Blockers/adverse effects
KW - Aspirin/adverse effects
KW - Atrial Fibrillation/drug therapy
KW - Biphenyl Compounds/adverse effects
KW - Clopidogrel
KW - Drug Therapy, Combination
KW - Follow-Up Studies
KW - Hemorrhage/chemically induced
KW - Humans
KW - Intracranial Embolism/prevention & control
KW - Irbesartan
KW - Myocardial Infarction/prevention & control
KW - Platelet Aggregation Inhibitors/adverse effects
KW - Randomized Controlled Trials as Topic
KW - Tetrazoles/adverse effects
KW - Thromboembolism/prevention & control
KW - Ticlopidine/adverse effects
U2 - 10.1007/s00108-007-1900-3
DO - 10.1007/s00108-007-1900-3
M3 - SCORING: Zeitschriftenaufsatz
C2 - 17628764
VL - 48
SP - 874
EP - 875
JO - INTERNIST
JF - INTERNIST
SN - 0020-9554
IS - 8
ER -